cGxP.wire https://validator.w3.org/feed/docs/rss2.html GE HealthCare Advances Cardiac Ultrasound With AI-Enabled Vivid Imaging Systems Nicox Sets April 2027 FDA Decision Date for NCX 470 Quoin Pharmaceuticals Reports Positive Interim Phase 2/3 Data for QRX003 in Netherton Syndrome Samsung Biologics Plans KRW 3 Trillion Rights Offering Roche’s Vabysmo Enables Extended 20-Week Dosing in PCV Patients Rectify Advances RTY-406 as Potential Disease-Modifying Therapy for PSC DualityBio and Genentech Partner on Next-Gen ADCs Catheter Precision Secures LockeT Orders and First German VIVO Placement Verrica Advances YCANTH Toward Potential FDA Approval for Common Warts Leo Cancer Care and GE HealthCare Advance Radiation Therapy Cardurion Announces Late-Breaking Phase 2 Tovinontrine Results in Heart Failure AES Cleanroom Technology Gains FM 4882 Approval MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Canvuparatide CytomX Wins FDA Fast Track Designation for Varseta-M in Metastatic Colorectal Cancer Propanc Advances PRP After Strong Preclinical Pancreatic Cancer Results Fresenius Medical Care Reports Lower Mortality With HDF Pillar Biosciences Expands Automated NGS Cancer Workflow Priovant Wins FDA Approval for Lisraya in Dermatomyositis argenx Completes Forte Biosciences Acquisition for FB102 Roivant Wins FDA Approval for LISRAYA in Dermatomyositis FDA Authorizes Bimectin for New World Screwworm HUTCHMED Wins NMPA Approval for ATLED in ICC iECURE Reports 74% Reduction in OTC-HOPE Crises FDA Approves Janssen’s Imaavy for Rare Blood Disorder Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration ViiV Healthcare’s Tivicay PD Wins FDA Approval for Kids HighLife Wins CE Mark for Next-Gen Clarity Valve Kazia Reports 100% Benefit in Advanced TNBC Patients AusperBio Raises $120M to Advance Next-Gen HBV Therapies Akeso Reports 2026 Growth, Advances Global Drug Pipeline Gilead Wins FDA Approval for Bixlenvo HIV Single Tablet Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC Pfizer and BioNTech Win FDA Approval for XFG COVID-19 Vaccine Polaryx Advances SOTERIA Phase 2 Trial Readiness Zymeworks Wins FDA Approval for Ziihera in HER2+ GEA Tempus AI Wins FDA Clearance for ECG Pulmonary Hypertension Tool Spyre Reports SPY072 Rheumatoid Arthritis Phase 2 Results 4basebio and Genezen Expand Synthetic DNA Collaboration Nxera Pharma Earns $10M Milestone as Neurocrine Wins FDA Acceptance for Alzheimer’s Phase 2 Study Summit Therapeutics Reports Positive Phase III BTC Results HepaRegeniX: FDA Grants Orphan Drug Status to Darizmetinib Cellenkos Wins FDA Fast Track for CK0803 in ALS Harbour BioMed Advances Antibody Pipeline and AI Strategy IMUNON Highlights Phase 3 OVATION 3 Trial at R&D Day Caris Life Sciences Links AI to Longer Survival in Pancreatic Cancer NeoGenomics Gains Medicare Coverage for RaDaR ST Monitoring FibroBiologics Releases Third CYWC628 Batch for DFU Trial Natera and Angiex Partner to Track AGX101 Response Spineart Gains FDA Clearance for PERLA TL Robotic Use Daiichi Sankyo Begins Phase 1 Trial of CD25 ADC DS1025